The conflict in the Middle East unsettled markets and interrupted what many investors had expected to be a steady start to the year. As the shock has lingered into a fifth week of elevated volatility, market internals now present a different landscape where rapid price corrections have opened up distinct opportunities in the small-cap space.
Corrections do not just create risk; they also create mispricings that can be exploited when fundamentals and momentum realign. That is the premise behind a small-cap-focused strategy that has sought out under-followed, high-growth names where price dislocations became larger and more frequent amid the recent turbulence. According to performance figures maintained for this strategy, it has delivered a total return of 43.27% since launch.
Performance metrics for the strategy through the recent period include:
- Year-to-date return in 2026 of +9.96%.
- Outperformance versus its benchmark by +14.05 percentage points so far this year.
- Cumulative total return since launch of +43.27%.
- Outperformance versus the benchmark since launch by +38.20 percentage points.
Subscribers to the premium service associated with the strategy were able to access AI-generated stock selections ahead of some of the moves that developed, with the subscription priced at less than $9 a month. The strategy’s designers emphasize that the underlying names were chosen because they exhibited the quantitative signals the model prioritizes.
Why small caps can show outsized moves is straightforward: they typically attract less analyst coverage and liquidity, so shifts in revenue momentum, investor flows or earnings surprises can lead to rapid repricing. The AI-based process that drives the Small Cap Sprinters strategy refreshes its holdings monthly, selecting up to 20 names from a broad universe while scanning for early signals such as sudden revenue acceleration, spikes in trading volume, and changes in investor demand. The system references more than 150 financial models built on more than 15 years of global data, and it rebalances with equal weighting across positions to provide a transparent measure of identification and timing effectiveness.
Because small-cap moves tend to be fast, the portfolio is dynamic: new names are added as opportunities appear, existing positions are held while momentum builds, and others are removed once the move plays out. The stated objective is to remain ahead of where growth and attention are likely to move next.
Two recent examples illustrate how this process picked stocks that have begun to rebound.
Myriad Genetics
Myriad Genetics Inc was flagged as a potential rebound candidate and has risen roughly 8.94% in the week following the signal. The stock had sold off sharply and at the time of the AI flag was trading at approximately 40% of its 52-week high and well under a cited analyst target of about $7.78. The business itself showed signs of operational improvement: management flipped a previously projected loss into a profit and reported results that beat earnings expectations. Key growth segments performed strongly, with hereditary cancer revenue up 9% and prostate cancer revenue up 12% during the reported period.
The company is positioned to launch three products in 2026, including an AI-powered test, and management projects full-year revenue in a range of $860 million to $880 million along with nearly 47% growth in EBITDA. Those fundamental indicators are the type that can help rebuild momentum after a steep price decline.
Inspire Medical Systems
Another small-cap name highlighted by the AI process, Inspire Medical Systems, climbed more than 9% in a single week. The stock had been trading around 34% of its 52-week high despite what the AI identified as continued underlying business strength. For the most recent fiscal year, revenue for Inspire rose about 14% to $912 million while EBITDA expanded by over 50%. Fourth-quarter earnings came in significantly ahead of expectations, and the company reported margins around 85%—an unusually high margin figure for a company at that growth rate.
A notable catalyst that has already occurred for Inspire was the introduction of a new CMS reimbursement code, which at one point pushed the stock up about 40% in a single day. The market opportunity referenced for the product area remains large, cited as greater than $10 billion and still largely untapped, which underpins the potential for continued adoption and momentum if commercial execution proceeds as projected.
These two names reflect the kind of setups the strategy targets: deeply discounted share prices relative to recent highs, paired with improving or strong fundamental metrics and identifiable catalysts that can accelerate investor interest.
For investors wondering whether a flagged name such as Myriad is currently part of any AI-driven strategies, the methodology evaluates each candidate against more than 100 financial metrics, balancing fundamentals, momentum, and valuation to determine risk-reward. The approach is described as unbiased, focused on data-driven selection rather than popularity, and it has previously identified other strong performers cited in strategy materials.
In summary, the recent conflict-driven market shock widened pricing inefficiencies in small caps. For those with access to data-driven screening and timely alerts, that created opportunities to identify under-followed companies where improving fundamentals and discrete catalysts could enable strong rebounds. But the market environment that produced those discounts remains volatile, and the small-cap segment tends to move quickly, which raises implementation and timing considerations for investors.